(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.85%) $83.14
(-1.16%) $1.619
(-0.46%) $2 336.40
(0.89%) $27.50
(0.55%) $927.20
(-0.17%) $0.933
(-0.14%) $11.01
(-0.24%) $0.798
(0.00%) $92.17
Live Chart Being Loaded With Signals
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory...
Stats | |
---|---|
本日の出来高 | 33.00 |
平均出来高 | 12 280.00 |
時価総額 | 307.68M |
EPS | $0.220 ( 2023-11-14 ) |
次の収益日 | ( $0 ) 2024-06-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 5.35 |
ATR14 | $0 (0.00%) |
Procaps Group S.A. 相関
10 最も負の相関 | |
---|---|
PROF | -0.973 |
ARTEU | -0.97 |
ACLS | -0.969 |
JMAC | -0.967 |
CFFE | -0.965 |
BRAC | -0.965 |
GENQ | -0.963 |
FMIV | -0.961 |
AHRN | -0.961 |
HERA | -0.96 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Procaps Group S.A. 財務諸表
Annual | 2022 |
収益: | $409.92M |
総利益: | $239.57M (58.44 %) |
EPS: | $0.420 |
FY | 2022 |
収益: | $409.92M |
総利益: | $239.57M (58.44 %) |
EPS: | $0.420 |
Financial Reports:
No articles found.
Procaps Group S.A.
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。